Clinical trials recruiting for Lung Cancer (Diagnosis)
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Florida | 3 |
| New York | 3 |
| Pennsylvania | 3 |
| California | 2 |
| Illinois | 2 |
| Massachusetts | 2 |
| North Dakota | 2 |
| Texas | 2 |
| Wisconsin | 2 |
| Colorado | 1 |
| Connecticut | 1 |
| Georgia | 1 |
Top cities
Self-screener
Recruiting trials
- A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
- A Study Measuring Markers of Airway Inflammation in Breath Samples From People With Respiratory Diseases and Healthy Volunteers.
- Accuracy Between Transthoracal Needle Aspiration (TTNA) Techniques in Suspected Lung Cancer Patients
- Acupressure for Cough in Lung Cancer Survivors
- Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
- Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
- Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
- Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary?
- EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
- Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.
- Enhanced COPD Management in Suspected Lung Cancer Patients
- Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
- Immune Cells Role in Lung Cancer and Their Use in Anticancer Immunotherapies and Inflammatory Lung Disease
- Increasing Lung Cancer Screening Uptake Among Emergency Department Patients
- Investigation of the Effects of Tele-Yoga Training in Individuals With Lung Cancer Undergoing Lung Resection Surgery
- Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site
- Multi-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
- Nitride-Based Raman Biochip for Lung Cancer Diagnosis and Monitoring
- Non-Invasive Malignancy Classifiers Using Blood-Biomarkers for Lung Nodule Evaluation
- Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics
- Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
- Promoting Radon Testing Among Mothers of Young Children
- Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis
- Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance
- Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
- Telehealth Collaborative Care Model (CoCM) in Lung Cancer
- The Effects of Low Intensity Endurance Exercise on Improving Mitochondrial Function, Cell Bioelectrical Impedance Phase Angle, Fatigue and Quality of Life in Lung Cancer Patients With Cancer-related Fatigue
- Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
Related conditions
Trials recruiting for Lung Cancer (Diagnosis) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Cancer (Diagnosis) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.